title: Drugs: a tangled web of targets.
authors.forename: Lauren
authors.initials: L
authors.lastname: Gravitz
mesh_terms: D000409:Alanine / Q000009:adverse effects / Q000031:analogs & derivatives; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D053829:Amyloid Precursor Protein Secretases / Q000037:antagonists & inhibitors / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001381:Azepines / Q000009:adverse effects; D002986:Clinical Trials as Topic; D018450:Disease Progression; D015316:Genetic Therapy; D038362:Glycogen Synthase Kinase 3 / Q000037:antagonists & inhibitors / Q000378:metabolism; D006801:Humans; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use; D008559:Memantine / Q000494:pharmacology / Q000627:therapeutic use; D008751:Methylene Blue / Q000627:therapeutic use; D058990:Molecular Targeted Therapy / Q000706:statistics & numerical data / Q000639:trends; D020932:Nerve Growth Factor / Q000235:genetics / Q000627:therapeutic use; D016874:Neurofibrillary Tangles / Q000187:drug effects; D010766:Phosphorylation; D016875:tau Proteins / Q000737:chemistry / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001381:Azepines; D007211:Indoles; C484278:N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide; D016875:tau Proteins; D020932:Nerve Growth Factor; D038362:Glycogen Synthase Kinase 3; D053829:Amyloid Precursor Protein Secretases; C545458:bapineuzumab; C010119:latrepirdine; D000409:Alanine; D008751:Methylene Blue; D008559:Memantine